IGC Pharma (IGC) Common Equity (2011 - 2026)
IGC Pharma (IGC) recorded Common Equity of $6.12 million in Q4 2026, down 3.3% from $6.33 million a year earlier and down 17.5% from the prior quarter.
Powered by 
Analysis
IGC Pharma (IGC) Common Equity (2011 - 2026) Analysis & Trends
Starting with Q4 2011, IGC Pharma's Common Equity history includes 61 quarters.
- Annual Common Equity has declined for five straight years, with a five-year compound annual growth rate of -28.5% (FY2021 to FY2026).
- Across earlier years, Common Equity came in at $6.33 million in FY2025 (-13.5%), $7.32 million in FY2024 (-50.9%), $14.91 million in FY2023 (-37.6%) and $23.89 million in FY2022 (-27.2%).
- Quarterly Common Equity has ranged from $6.08 million in Q1 2026 to $31.74 million in Q1 2022 over the past five years.
- On a year-over-year basis, Common Equity rose in two of the last eight quarters, with an average decline of 16.3%.
- Peak year-over-year performance for Common Equity in the last five years was growth of 37.3% in Q3 2022, against a decline of 50.9% in Q4 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at $7.42 million (Q3 2026), $8.09 million (Q2 2026) and $6.08 million (Q1 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 41.98 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 50.37 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 11.69 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 11.83 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 85.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 20.25 Bn |
| 10 | IGC Pharma | 26.67 Mn | 23.92 Mn | 55,000.00 | 6.12 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 6.12 Mn |
| Dec 31, 2025 | 7.42 Mn |
| Sep 30, 2025 | 8.09 Mn |
| Jun 30, 2025 | 6.08 Mn |
| Mar 31, 2025 | 6.33 Mn |
| Dec 31, 2024 | 6.26 Mn |
| Sep 30, 2024 | 7.38 Mn |
| Jun 30, 2024 | 7.88 Mn |
| Mar 31, 2024 | 7.32 Mn |
| Dec 31, 2023 | 9.05 Mn |
| Sep 30, 2023 | 14.10 Mn |
| Jun 30, 2023 | 13.20 Mn |
| Mar 31, 2023 | 14.91 Mn |
| Dec 31, 2022 | 18.32 Mn |
| Sep 30, 2022 | 20.14 Mn |
| Jun 30, 2022 | 22.04 Mn |
| Mar 31, 2022 | 23.89 Mn |
| Dec 31, 2021 | 29.48 Mn |
| Sep 30, 2021 | 31.26 Mn |
| Jun 30, 2021 | 31.74 Mn |
API Access
IGC Pharma Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=IGC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "IGC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=IGC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();